Traduction de «Cerebellar syndrome » (Anglais → Néerlandais) :

cerebellar syndrome
afgrondenvrees | cremnophobie

Corneal cerebellar syndrome
syndroom van Der Kaloustian-Jarudi-Khoury

Disease with characteristics of cerebellar syndrome along with altered vertical eye movements. Reported in nine members of Spanish kindred to date. Disease onset occurs in adulthood (from the ages of 38-64). Clinical manifestations are slowly progres
spinocerebellaire ataxie type 37

Main features described as slowly progressive cerebellar syndrome and epilepsy, sometimes mild pyramidal signs, peripheral neuropathy and neuropsychological disturbances. Prevalence is unknown. Many kindreds have been found in Mexican and Brazilian p
spinocerebellaire ataxie type 10

congenital cerebellar ataxia | Marie disease | Marie's cerebellar ataxia | Marie's disease | Nonne-Marie sydrome
erfelijke cerebellaire ataxie

Arnold-Chiari malformation | cerebellar ectopia | Chiari malformation | herniation of the cerebellar tonsils | hindbrain herniation
Chiari malformatie

Hereditary cerebellar:ataxia NOS | degeneration | disease | syndrome
hereditair(e) cerebellair(e) | ataxie NNO | hereditair(e) cerebellair(e) | degeneratie | hereditair(e) cerebellair(e) | syndroom | hereditair(e) cerebellair(e) | ziekte

Cerebellar stroke syndrome (I60-I67+)
vasculair syndroom van cerebellum (I60-I67)

cerebellar | brain-related
cerebellair | met betrekking tot de kleine hersenen

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...
Omschrijving: Dit blok omvat een grote verscheidenheid van stoornissen van verschillende ernst en klinische vorm, die evenwel alle aan het gebruik van een of meer psychoactieve middelen, al dan niet op medisch voorschrift, zijn toe te schrijven. De betrokken stof wordt aangegeven door middel van het derde teken van de code en het vierde teken specificeert de klinische toestand; deze codering dient, waar nodig, gebruikt te worden voor elk gespecificeerd middel, met dien verstande dat niet elk vierde teken van toepassing is op elke stof.